These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1. Hoorelbeke B; Xue J; LiWang PJ; Balzarini J PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304 [TBL] [Abstract][Full Text] [Related]
6. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. François KO; Auwerx J; Schols D; Balzarini J Mol Pharmacol; 2008 Aug; 74(2):330-7. PubMed ID: 18474667 [TBL] [Abstract][Full Text] [Related]
7. Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions. Auwerx J; François KO; Vanstreels E; Van Laethem K; Daelemans D; Schols D; Balzarini J Antiviral Res; 2009 Jul; 83(1):61-70. PubMed ID: 19514109 [TBL] [Abstract][Full Text] [Related]
8. The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. Férir G; Petrova MI; Andrei G; Huskens D; Hoorelbeke B; Snoeck R; Vanderleyden J; Balzarini J; Bartoschek S; Brönstrup M; Süssmuth RD; Schols D PLoS One; 2013; 8(5):e64010. PubMed ID: 23724015 [TBL] [Abstract][Full Text] [Related]
9. Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection. Balzarini J; Hatse S; Vermeire K; Princen K; Aquaro S; Perno CF; De Clercq E; Egberink H; Vanden Mooter G; Peumans W; Van Damme E; Schols D Antimicrob Agents Chemother; 2004 Oct; 48(10):3858-70. PubMed ID: 15388446 [TBL] [Abstract][Full Text] [Related]
10. Vaginal microbiota and its role in HIV transmission and infection. Petrova MI; van den Broek M; Balzarini J; Vanderleyden J; Lebeer S FEMS Microbiol Rev; 2013 Sep; 37(5):762-92. PubMed ID: 23789590 [TBL] [Abstract][Full Text] [Related]
11. Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness. Mathys L; Balzarini J J Antimicrob Chemother; 2014 Mar; 69(3):582-93. PubMed ID: 24144923 [TBL] [Abstract][Full Text] [Related]
12. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions. Bertaux C; Daelemans D; Meertens L; Cormier EG; Reinus JF; Peumans WJ; Van Damme EJ; Igarashi Y; Oki T; Schols D; Dragic T; Balzarini J Virology; 2007 Sep; 366(1):40-50. PubMed ID: 17498767 [TBL] [Abstract][Full Text] [Related]
13. NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles. Gordts SC; Renders M; Férir G; Huskens D; Van Damme EJ; Peumans W; Balzarini J; Schols D J Antimicrob Chemother; 2015; 70(6):1674-85. PubMed ID: 25700718 [TBL] [Abstract][Full Text] [Related]
14. A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides. Van Herrewege Y; Michiels J; Waeytens A; De Boeck G; Salden E; Heyndrickx L; van den Mooter G; de Béthune MP; Andries K; Lewi P; Praet M; Vanham G Antiviral Res; 2007 May; 74(2):111-24. PubMed ID: 17097156 [TBL] [Abstract][Full Text] [Related]
15. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells. Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806 [TBL] [Abstract][Full Text] [Related]
16. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli. Pusch O; Kalyanaraman R; Tucker LD; Wells JM; Ramratnam B; Boden D AIDS; 2006 Oct; 20(15):1917-22. PubMed ID: 16988512 [TBL] [Abstract][Full Text] [Related]
17. Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs). Férir G; Vermeire K; Huskens D; Balzarini J; Van Damme EJ; Kehr JC; Dittmann E; Swanson MD; Markovitz DM; Schols D Antiviral Res; 2011 Jun; 90(3):200-4. PubMed ID: 21501631 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Chang TL; Chang CH; Simpson DA; Xu Q; Martin PK; Lagenaur LA; Schoolnik GK; Ho DD; Hillier SL; Holodniy M; Lewicki JA; Lee PP Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11672-7. PubMed ID: 12972635 [TBL] [Abstract][Full Text] [Related]
19. Parameters of inhibition of HIV-1 infection by small anionic microbicides. Vzorov AN; Bozja J; Dixon DW; Marzilli LG; Compans RW Antiviral Res; 2007 Jan; 73(1):60-8. PubMed ID: 16949681 [TBL] [Abstract][Full Text] [Related]
20. Algal lectins as potential HIV microbicide candidates. Huskens D; Schols D Mar Drugs; 2012 Jul; 10(7):1476-1497. PubMed ID: 22851920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]